These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12850429)

  • 1. The rotenone model of Parkinson's disease.
    Perier C; Bové J; Vila M; Przedborski S
    Trends Neurosci; 2003 Jul; 26(7):345-6. PubMed ID: 12850429
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroscience. Pesticide causes Parkinson's in rats.
    Helmuth L
    Science; 2000 Nov; 290(5494):1068. PubMed ID: 11184997
    [No Abstract]   [Full Text] [Related]  

  • 3. Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease.
    Caboni P; Sherer TB; Zhang N; Taylor G; Na HM; Greenamyre JT; Casida JE
    Chem Res Toxicol; 2004 Nov; 17(11):1540-8. PubMed ID: 15540952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.
    Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
    Behav Brain Res; 2013 Apr; 243():6-15. PubMed ID: 23295396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
    Carriere CH; Kang NH; Niles LP
    Neuroscience; 2014 May; 267():114-21. PubMed ID: 24613722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone.
    Fleming SM; Zhu C; Fernagut PO; Mehta A; DiCarlo CD; Seaman RL; Chesselet MF
    Exp Neurol; 2004 Jun; 187(2):418-29. PubMed ID: 15144868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
    Verma R; Nehru B
    Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease.
    Khurana N; Gajbhiye A
    Neurotoxicology; 2013 Dec; 39():57-64. PubMed ID: 23994302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone.
    Mulcahy P; Walsh S; Paucard A; Rea K; Dowd E
    Neuroscience; 2011 May; 181():234-42. PubMed ID: 21277943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenone-induced parkinsonism and L-dopa toxicity.
    Abdin AA; Sarhan NI
    Neurosci Res; 2011 Dec; 71(4):387-95. PubMed ID: 21889550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial complex I inhibition depletes plasma testosterone in the rotenone model of Parkinson's disease.
    Alam M; Schmidt WJ
    Physiol Behav; 2004 Dec; 83(3):395-400. PubMed ID: 15581661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D₁ and D₂ receptor subtypes functional regulation in cerebral cortex of unilateral rotenone lesioned Parkinson's rat model: Effect of serotonin, dopamine and norepinephrine.
    Paul J; Kuruvilla KP; Mathew J; Kumar P; Paulose CS
    Parkinsonism Relat Disord; 2011 May; 17(4):255-9. PubMed ID: 21306935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration.
    Uversky VN
    Cell Tissue Res; 2004 Oct; 318(1):225-41. PubMed ID: 15258850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
    Nehru B; Verma R; Khanna P; Sharma SK
    Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REM sleep deprivation generates cognitive and neurochemical disruptions in the intranigral rotenone model of Parkinson's disease.
    Dos Santos AC; Castro MA; Jose EA; Delattre AM; Dombrowski PA; Da Cunha C; Ferraz AC; Lima MM
    J Neurosci Res; 2013 Nov; 91(11):1508-16. PubMed ID: 23908011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats.
    Karuppagounder SS; Madathil SK; Pandey M; Haobam R; Rajamma U; Mohanakumar KP
    Neuroscience; 2013 Apr; 236():136-48. PubMed ID: 23357119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
    Imamura K; Takeshima T; Kashiwaya Y; Nakaso K; Nakashima K
    J Neurosci Res; 2006 Nov; 84(6):1376-84. PubMed ID: 16917840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models.
    Xiong N; Long X; Xiong J; Jia M; Chen C; Huang J; Ghoorah D; Kong X; Lin Z; Wang T
    Crit Rev Toxicol; 2012 Aug; 42(7):613-32. PubMed ID: 22574684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease.
    Saravanan KS; Sindhu KM; Mohanakumar KP
    Brain Res; 2005 Jul; 1049(2):147-55. PubMed ID: 15936733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pesticide use linked to Parkinson's disease.
    Adam D
    Nature; 2000 Nov; 408(6809):125. PubMed ID: 11089940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.